“We’re looking for a symbiotic platform that will have a disruptive effect in a rapidly expanding ecosystem.” A private equity colleague of ours described this conversation, which he overheard at the most recent J.P. Morgan health care conference in San Francisco. Upwards of 30,000 deal professionals are reported to have descended on the city for the conference, and the town was ablaze in deal analysis and discussion. While perhaps this wasn’t exactly the conversation that was overheard, we can report (accurately) that once again we enjoyed, and are thoroughly exhausted from, several days of deal-making and conversation about trends and predictions for the coming year in health care private equity transactions.

To read about the trends from the conference in our latest Law360 column, written with our colleague Richard Grant, click here.